Cipla stock rises nearly 2% after USFDA grants VAI status to Goa plant
Shares of Cipla gained nearly 2 per cent on Monday, following the United States Food and Drug Administration (USFDA) classifying
Continue reading
Tag: Cipla pending ANDAs launch